Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The study has demonstrated a strong trend that adjuvant therapy with Septilin and Bresol along with SOC, supports immunity and controls inflammation in COVID-19-positive patients and helps in the recovery of symptoms of 'post-COVID-19 illness'.
Lead Product(s): Guggulu,Yashtimadhu,Guduchi
Therapeutic Area: Infections and Infectious Diseases Product Name: Septilin
Highest Development Status: UndisclosedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 10, 2020